Patents/Assignees

Kalivir Immunotherapeutics, Inc.

6 patents in portfolio

US12472217utility2025
Platform Oncolytic Vector for Systemic Delivery
0 cites
US12318419utility2025
Platform Oncolytic Vector for Systemic Delivery
0 cites
US12226440utility2025
Platform Oncolytic Vector for Systemic Delivery
0 cites
US12036257utility2024
Platform Oncolytic Vector for Systemic Delivery
0 cites
US12016893utility2024
Oncolytic Viruses for Modified MHC Expression
0 cites
US11963990utility2024
Oncolytic Viruses for Modified MHC Expression
0 cites